The effect of enterolactone on liver lipid precursors of inflammation.
4-Butyrolactone
/ analogs & derivatives
Eicosanoids
Fatty Acids
Fatty Acids, Nonesterified
/ analysis
Fatty Acids, Omega-3
Fatty Acids, Unsaturated
Hep G2 Cells
/ drug effects
Hepatocytes
Humans
Inflammation
/ drug therapy
Lignans
/ metabolism
Lipid Metabolism
Lipids
Liver
/ drug effects
Palmitic Acid
/ pharmacology
Prostaglandins
Triglycerides
/ analysis
Enterolactone
Fatty acids
Hepatocytes
Inflammation
Nonalcoholic fatty liver disease
Journal
Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521
Informations de publication
Date de publication:
15 Mar 2019
15 Mar 2019
Historique:
received:
09
01
2019
revised:
20
02
2019
accepted:
21
02
2019
pubmed:
26
2
2019
medline:
4
4
2019
entrez:
26
2
2019
Statut:
ppublish
Résumé
The aim of this study was to assess the effects of enterolactone (ENL) on lipid fractions fatty acids composition affecting hepatocyte inflammation development. The experiments were conducted in HepG2 cells incubated with ENL and/or palmitic acid (16 h). Intracellular contents of free fatty acids (FFA), di- (DAG) and tri- (TAG) acylglycerol as well as their fatty acids compositions were assessed by Gas-Liquid Chromatography. Moreover, the ω-6/ω-3 ratios in the above mentioned lipids fractions were estimated. The expression of proteins involved in eicosanoids and prostanoids production (COX-2, 15-LOX), inflammatory process (TNFα), as well as the proteins participating in the desaturation (SCD 1) and elongation (Elovl 3, Elovl 6) of fatty acids were evaluated by Western Blot. Enterolactone modified fatty acids composition in FFA, DAG and TAG fractions. In conjunction with lipid overload, it increased the content of ω-6 more than ω-3 PUFA. Moreover, it enhanced the expressions of Elovl 3, Elovl 6, COX-2 and TNFα, whereas it had no influence on SCD 1 and 15-LOX level. Our study revealed that the supplementation with ENL affected intracellular hepatic composition of saturated as well as unsaturated fatty acids in each of the investigated lipid fractions. Based on the shift in the ω-6/ω-3 balance towards ω-6, as well as the increase in COX-2 and TNFα protein expressions, we may postulate a pro-inflammatory nature of the examined polyphenol. Moreover, our findings could prove to be useful in the future research in the topic of widespread diseases such as NASH.
Identifiants
pubmed: 30802511
pii: S0024-3205(19)30134-1
doi: 10.1016/j.lfs.2019.02.044
pii:
doi:
Substances chimiques
Eicosanoids
0
Fatty Acids
0
Fatty Acids, Nonesterified
0
Fatty Acids, Omega-3
0
Fatty Acids, Unsaturated
0
Lignans
0
Lipids
0
Prostaglandins
0
Triglycerides
0
Palmitic Acid
2V16EO95H1
4-Butyrolactone
OL659KIY4X
2,3-bis(3'-hydroxybenzyl)butyrolactone
X01E7E1D6H
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
341-347Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.